NewsRSS3 days ago
A patient with AATD (a rare lung disease caused by low levels of a protective protein) shares her personal experiences with complementary and alternative medicine approaches. She discusses how nontraditional treatments have fit into her overall care plan alongside standard medical treatment. The article reflects one patient's perspective on combining different types of medicine to manage her condition.
WHY IT MATTERSPatients with AATD can learn from one person's real-world experience balancing conventional treatment with complementary approaches, which may help inform their own conversations with their healthcare team about what options exist.
NewsRSS3 days ago
A person who used to work as a nutrition counselor shares what it's really like to have a good day while living with AATD (alpha-1 antitrypsin deficiency). The article shows how much planning, careful decisions, and inner strength it takes to manage this rare lung disease day-to-day. Even on good days, people with AATD have to think carefully about their choices and energy levels.
WHY IT MATTERSThis firsthand account helps patients and caregivers understand that managing AATD requires constant invisible effort, which can validate their own experiences and help them feel less alone.
ResearchRSS3 days ago
Researchers found that data from smartphones and wearable devices, collected over several years through a health app, can help doctors identify people with a rare lung disease called idiopathic pulmonary arterial hypertension (IPAH) earlier than before. The study used information like heart rate and activity levels from the My Heart Counts app to spot differences between people with IPAH and healthy people. This discovery could lead to faster diagnosis of this serious condition.
WHY IT MATTERSEarlier detection of IPAH could allow patients to start treatment sooner, potentially slowing disease progression and improving outcomes for this condition that currently has no cure.
NewsRSS3 days ago
A person with pulmonary hypertension (PH), a rare lung disease that makes it hard for the heart to pump blood through the lungs, shares what it was like growing up with this condition. They had to frequently miss school and explain their illness to classmates who asked questions about their absences. This article highlights the social and emotional challenges that young people with chronic rare diseases face alongside their medical treatment.
WHY IT MATTERSPatients with pulmonary hypertension and their families can find validation and community in peer experiences, while healthcare providers gain insight into the psychosocial impact of PH that extends beyond physical symptoms.
ResearchPUBMEDMar 26
Doctors who treat children with rare lung diseases in German-speaking countries were surveyed about their experience and confidence in diagnosing and treating these conditions. The study found that while common rare lung diseases like cystic fibrosis have good support systems, many other rare lung diseases don't have clear treatment guidelines. Researchers want to understand what training and resources doctors need to better help children with these uncommon lung problems.
WHY IT MATTERSIf you have a child with a rare lung disease, this research could lead to better training for pediatric lung doctors in your region, potentially reducing diagnostic delays and improving access to specialized care.
ResearchPUBMEDMar 26
Doctors found a rare lung disease called pulmonary light chain deposition disease (PLCDD) that creates cysts and bumps in the lungs. This disease is hard to diagnose because it looks similar to other lung conditions, but special imaging scans and blood tests for abnormal proteins can help identify it. The article explains how doctors should think about this disease when patients have unusual cyst patterns in their lungs.
WHY IT MATTERSIf you have been diagnosed with an unusual cystic lung disease that doesn't fit typical patterns, your doctor should consider testing for light chain deposition disease, which requires specific blood work and imaging to confirm.
Clinical trialCLINICALTRIALSMar 26
Doctors are building a national database to collect information from 500 patients with pulmonary alveolar proteinosis (PAP), a rare lung disease. This registry will help researchers better understand PAP, improve how doctors diagnose it, and test new treatments. Patients who join will have a voice in deciding what research gets done.
WHY IT MATTERSThis is an active recruitment opportunity for PAP patients to directly influence research priorities and gain access to new diagnostic tests and experimental therapies being evaluated through the registry.